Seeing Is Believing
Currently out of the existing stock ratings of Olivia Brayer, 76 are a BUY (64.96%), 41 are a HOLD (35.04%).
Analyst Olivia Brayer, currently employed at BAIRD, carries an average stock price target met ratio of 58.33% that have a potential upside of 30.97% achieved within 123 days. Previously, Olivia Brayer worked at CANTOR FITZGERALD, BAML.
Olivia Brayer’s has documented 231 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INSM, Insmed at 10-Jun-2026.
Analyst best performing recommendations are on CTMX (CYTOMX THERAPEUTICS).
The best stock recommendation documented was for BMY (BRISTOL-MYERS SQUIBB COMPANY) at 7/22/2024. The price target of $45 was fulfilled within 4 days with a profit of $6.11 (15.71%) receiving and performance score of 39.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Oct-2021
$354
$122.17 (52.70%)
$475
8 days ago
(15-Oct-2026)
6/7 (85.71%)
$119.97 (51.26%)
211
Buy Since 19-May-2026
$320
$88.17 (38.03%)
$340
9 days ago
(14-Oct-2026)
0/3 (0%)
$95.53 (42.56%)
Hold Since 20-Oct-2025
$253
$21.17 (9.13%)
$256
9 days ago
(14-Oct-2026)
2/7 (28.57%)
$28.53 (12.71%)
38
Buy Since 20-Sep-2022
$345
$113.17 (48.82%)
$350
15 days ago
(08-Oct-2026)
31/38 (81.58%)
$120.47 (53.65%)
180
Buy Since 15-May-2025
$369
$137.17 (59.17%)
$375
23 days ago
(30-Sep-2026)
9/12 (75%)
$122.26 (49.55%)
30
Which stock is Olivia Brayer most bullish on?
What Year was the first public recommendation made by Olivia Brayer?